NBN, RAD51 and XRCC3 Polymorphisms as Potential Predictive Biomarkers of Adjuvant Radiotherapy Toxicity in Early HER2-Positive Breast Cancer
Article in Cancers (September 2022)
The most recent citing publications are shown below. View all 14 publications that cite this research output on Dimensions.
Article in Cancers (September 2022)
Article in OncoTargets and Therapy (July 2018)
Article in BioMed Research International (August 2016)